Clinical trial
Comparison of Continuous Subcutaneous Insulin Infusion (CSII) With Multiple Daily Injections (MDI) for the Treatment of Pregestational Diabetes During Pregnancy
NCT02064023 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Continuous Subcutaneous Insulin Infusion (CSII) With Multiple Daily Injections (MDI) for the Treatment of Pregestational Diabetes During Pregnancy
- Lead sponsor
- University of British Columbia
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2014
- Completion date
- December 4, 2015
- Enrollment
- 2 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
pregnancy, type 1 diabetes, type 2 diabetes